Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus.

MLA

Loong, Tan Han, et al. “Serum Pepsinogen and Gastrin-17 as Potential Biomarkers for Pre-Malignant Lesions in the Gastric Corpus.” Biomedical Reports, vol. 7, no. 5, Nov. 2017, pp. 460–68. EBSCOhost, https://doi.org/10.3892/br.2017.985.

APA

Loong, T. H., Soon, N. C., Nik Mahmud, N. R. K., Naidu, J., Rani, R. A., Abdul Hamid, N., Elias, M. H., Mohamed Rose, I., Tamil, A., Mokhtar, N. M., & Raja Ali, R. A. (2017). Serum pepsinogen and gastrin-17 as potential biomarkers for pre-malignant lesions in the gastric corpus. Biomedical Reports, 7(5), 460–468. https://doi.org/10.3892/br.2017.985

Chicago

Loong, Tan Han, Ngiu Chai Soon, Nik Ritza Kosai Nik Mahmud, Jeevinesh Naidu, Rafiz Abdul Rani, Nazefah Abdul Hamid, Marjanu Hikmah Elias, et al. 2017. “Serum Pepsinogen and Gastrin-17 as Potential Biomarkers for Pre-Malignant Lesions in the Gastric Corpus.” Biomedical Reports 7 (5): 460–68. doi:10.3892/br.2017.985.